grey arrow to go to previous Omnicell webpage or forward to next Omnicell pageBack to Press Release

October 17, 2019

Omnicell to Release Third Quarter 2019 Earnings Results on October 24, 2019

Download PDF

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Oct. 17, 2019-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, October 24, 2019, to discuss the Company’s Third Quarter 2019 financial results.


Omnicell Third Quarter 2019 earnings conference call and webcast


October 24, 2019, 1:30 p.m. PT


Randall Lipps, chairman, president, chief executive officer, and founder Peter Kuipers, chief financial officer


The conference call can be monitored by dialing 1-800-696-5518 within the U.S.

or 1-706-758-4883 for all other locations. The Conference ID # is 6695921.

The webcast can be accessed at:


Link to the Omnicell website 15 minutes prior to the call to download necessary audio software



Available starting at 4:30 p.m. PT on October 24, 2019, through 11:59 p.m. PT on November 22, 2019. Dial 1-855-859-2056 within the U.S. and 1-404-537-3406 for all other locations, Conference ID # 6695921

About Omnicell

Since 1992, Omnicell has been inspired to create safer and more efficient ways to manage medications across all care settings. Through its industry-leading medication management platform that spans the continuum of care, Omnicell is developing a vision for a fully automated infrastructure, powered by a cloud data platform that supports improved patient care, fewer errors, enhanced safety, and new opportunities for growth.

Omnicell's vision for the Autonomous Pharmacy integrates a comprehensive set of solutions across three key areas: automation solutions designed to digitize and streamline workflows; intelligence that provides actionable insights to better understand medication usage and improve pharmacy supply chain management; and work - expert services that serve as an extension of pharmacy operations to support improved efficiency, regulatory compliance, and patient outcomes.

Over 5,500 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 40,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence solutions designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

To learn more about Omnicell and its Autonomous Pharmacy vision, please visit


Source: Omnicell, Inc.

Peter Kuipers Omnicell, Inc.
Chief Financial Officer 590 E. Middlefield Road
800-850-6664, Mountain View, CA 94043